PMEF
AGL icon

Point72 Middle East FZE’s Agilon Health AGL Stock Holding History

Point72 Middle East FZE’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-710
Closed -$422K – 1502
2023
Q1 		$422K Buy
710
+434
+157% +$243K 0.01% 734
2022
Q4 		$111K Buy
+276
New +$129K ﹤0.01% 1234

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Middle East FZE's AGL Position: Q2 2023 in Review

Point72 Middle East FZE sold out of Agilon Health (AGL) in Q2 2023, closing a stake of 710 shares — an estimated $422K sold.

Point72 Middle East FZE first reported a position in AGL in Q4 2022 and held it in 2 quarters. The position peaked at $422K in Q1 2023. 185 funds tracked by Wall St. Rank hold AGL as of Q2 2023.

  • Point72 Middle East FZE reported no remaining Agilon Health position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 710 Agilon Health shares in Q2 2023, an estimated $422K.
  • Point72 Middle East FZE first reported a position in Agilon Health in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Agilon Health position peaked at $422K in Q1 2023.
  • 185 funds tracked by Wall St. Rank held Agilon Health as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.